TLCM
ARLZ

Tiger Legatus Capital Management’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Tiger Legatus Capital Management’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,985,000
Closed -$8.75M – 18
2016
Q4 		$8.75M Buy
1,985,000
+25,000
+1% +$119K 3.24% 13
2016
Q3 		$9.51M Buy
1,960,000
+460,000
+31% +$2.1M 3.09% 13
2016
Q2 		$4.95M Buy
1,500,000
+225,000
+18% +$849K 1.5% 18
2016
Q1 		$4.53M Buy
+1,275,000
New +$6.57M 1.8% 12

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Tiger Legatus Capital Management's ARLZ Position: Q1 2017 in Review

Tiger Legatus Capital Management sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q1 2017, closing a stake of 1,985,000 shares — an estimated $8.75M sold.

Tiger Legatus Capital Management first reported a position in ARLZ in Q1 2016 and held it in 4 quarters. The position peaked at $9.51M in Q3 2016. 78 funds tracked by Wall St. Rank hold ARLZ as of Q1 2017.

  • Tiger Legatus Capital Management reported no remaining Aralez Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • Tiger Legatus Capital Management sold 1,985,000 Aralez Pharmaceuticals Inc. shares in Q1 2017, an estimated $8.75M.
  • Tiger Legatus Capital Management first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 4 quarters.
  • Tiger Legatus Capital Management's Aralez Pharmaceuticals Inc. position peaked at $9.51M in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q1 2017.

Based on Tiger Legatus Capital Management's 13F filing for Q1 2017, filed 15 May 2017.